List view / Grid view
17 February 2014 | By The European Medicines Agency
The European Medicines Agency is pleased to welcome Dina Tsiambaou as the new Head of IT Development Department in the Information Technology Division...
17 February 2014 | By Merck
MSD Animal Health announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use, the European Commission has granted marketing authorization for the veterinary medicinal product BRAVECTO™...
17 February 2014 | By Boehringer Ingelheim
Boehringer Ingelheim Fremont Inc. received the East Bay Innovation Award in recognition for its contribution to the East Bay's culture of innovation...
17 February 2014 | By Biogen Idec
Stelios Papadopoulos to become Chairman of the Board...
14 February 2014 | By Daiichi Sankyo Company
Norovirus is one of the leading causes of infectious gastroenteritis and the number of infected people reported is increasing both in Japan and globally...
14 February 2014 | By GlaxoSmithKline
GlaxoSmithKline announced the start of a Phase III study to evaluate the efficacy and safety of mepolizumab, an investigational IL-5 antagonist, in patients with Eosinophilic Granulomatosis with Polyangiitis...
13 February 2014 | By Teva
24-month FDA post marketing commitment completed...
13 February 2014 | By Johnson & Johnson
Janssen Biotech, Inc. announced the U.S. Food and Drug Administration has approved IMBRUVICA™ (ibrutinib) capsules for the treatment of patients with chronic lymphocytic leukemia who have received at least one prior therapy...
12 February 2014 | By The European Medicines Agency
The European Medicines Agency has introduced unique product identifiers (UPIs) to track medicines through pre-authorisation procedures...
12 February 2014 | By Pfizer
Pfizer agrees with the recommendation of the joint meeting of the FDA Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee...
12 February 2014 | By AbbVie
AbbVie Inc. announces a US$320 million investment to establish operations in Singapore for small molecule and biologics active drug substance manufacturing...
11 February 2014 | By kdm communications
Scientists working at the Leibniz-Institute for Molecular Pharmacology (FMP) in Berlin, Germany, are benefitting from the low volume pipetting capability of a MultiChannel Arm™ (MCA) 384 for siRNA and small molecule screening...
11 February 2014 | By EMPERRA® GmbH
EMPERRA® GmbH E-Health Technologies announced the appointment of Dr. Christian Krey as Managing Director and CEO. Dr. Krey has many years of experience in the field of diabetes mellitus...
11 February 2014 | By The European Medicines Agency
The European Medicines Agency has clarified a number of points related to the new categories of variations to the terms of marketing authorisations that were introduced in August 2013. The related question and answer document has been updated to reflect these adjustments...
10 February 2014 | By The European Medicines Agency
The European Medicines Agency has published an update to its guidance for the annual strain change of influenza vaccines...
